Lifecore Biomedical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Lifecore Biomedical, Inc. (LFCR) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018
Operating Activities
Net Income-38.7212.01-99.56-116.72-32.67-38.190.4124.92
Depreciation & Amortization8.037.9513.1818.0619.8718.8415.2312.41
Deferred Income Tax0.000.160.36-6.83-7.89-5.440.91-7.22
Stock Based Compensation10.166.203.612.613.360.000.000.00
Change in Working Capital-4.70-3.707.37-0.565.62-25.48-1.43-12.08
Change in Accounts Receivable-2.26-2.3910.82-6.145.780.000.000.00
Change in Inventory7.690.86-14.81-2.18-2.820.000.000.00
Change in Accounts Payable-1.67-6.6816.049.34-5.980.000.000.00
Change in Other Working Capital-8.4517.271.07-0.4312.360.000.000.00
Other Operating Activities25.0217.275.8085.5025.6535.493.961.50
Net Cash from Operating Activities-0.210.26-17.44-22.5915.02-16.5419.5221.68
Investing Activities
Capital Expenditures-13.42-18.40-21.481.1423.7726.6944.7333.59
Acquisitions7.000.0016.6745.100.000.00-52.870.00
Sales/Maturities of Investments0.00-17.92-21.48-39.78-23.77-0.14-2.96-4.00
Other Investing Activities0.00-17.92-21.48-39.78-23.77-0.14-2.96-4.00
Net Cash from Investing Activities-6.42-18.40-4.8179.96-10.86-24.39-100.30-37.49
Financing Activities
Debt Repayment-18.56-147.42-184.38-131.34-273.01-105.03-39.09-14.08
Common Stock Issued23.850.724.820.000.000.030.330.06
Common Stock Repurchased0.00-0.15-0.27-0.79-0.410.000.000.00
Dividends Paid0.00-14.21-0.340.000.000.000.000.00
Other Financing Activities1.134.77-0.27-0.79-0.41-0.21-0.70-5.69
Net Cash from Financing Activities6.427.5139.70-57.02-3.4240.0279.0313.29
Summary
Net Change in Cash-0.20-10.6317.450.350.74-0.91-1.75-2.52
Cash at Beginning of Period8.4619.091.641.300.551.473.225.73
Cash at End of Period8.278.461.641.301.300.551.473.22
Free Cash Flow-13.62-18.14-17.44-21.4527.93-40.79-24.95-11.81
Supplemental Disclosures
Interest Paid1.912.7331.0216.8913.2210.135.612.29
Income Taxes Paid0.050.070.020.44-7.68-1.12-1.960.28